Webinar:
"Better than expected" - LC
Taking on the standard of care (H+Chemo) would take 10-15 years and 1000's of patients. That's the reason why a combination design for progression is preferred.
"Earlier line of therapy" is favourable to a greater response for HVaxx. Next horizon trial is to demonstrate this.
"Beautiful safety profile" - LC
"0.58 is something to be quite proud of" - LC
"100mg means more of our safe drug..." - LC
My clumsy typing and recollection only
Ann: Final HER-Vaxx Phase 2 Trial Overall Survival Results, page-145
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $371.8M | |||
| Open | High | Low | Value | Volume |
| 5.0¢ | 5.0¢ | 4.8¢ | $521.9K | 10.58M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 1612511 | 4.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.0¢ | 3882781 | 14 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |